Viking Therapeutics, Inc. Public Float
Viking Therapeutics, Inc. (VKTX) had Public Float of $2.98 billion as of 2025-06-30, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-11
- 2025-06-30: Entity Public Float $2.98B.
- 2024-06-30: Entity Public Float $4.00B.
- 2023-06-30: Entity Public Float $93.70M.
- 2022-06-30: Entity Public Float $195.97M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.98B 10-K · filed 2026-02-11 |
| 2024-06-30 | $4.00B 10-K · filed 2025-02-26 |
| 2023-06-30 | $93.70M 10-K · filed 2024-02-07 |
| 2022-06-30 | $195.97M 10-K · filed 2023-02-10 |
| 2021-06-30 | $417.14M 10-K · filed 2022-02-09 |
| 2020-06-30 | $469.58M 10-K · filed 2021-02-17 |
| 2019-06-28 | $534.93M 10-K · filed 2020-02-26 |
| 2018-06-29 | $500.01M 10-K · filed 2019-03-13 |
| 2017-06-30 | $21.41M 10-K · filed 2018-03-07 |
| 2016-06-30 | $14.17M 10-K · filed 2017-03-21 |
| 2015-06-30 | $18.29M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |